Plainsburo, NJ, United States of America

Kirti H Valia


Average Co-Inventor Count = 2.4

ph-index = 3

Forward Citations = 34(Granted Patents)


Location History:

  • Indianapolis, IN (US) (1993)
  • Plainsburo, NJ (US) (1997 - 1999)

Company Filing History:


Years Active: 1993-1999

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kirti H Valia: Innovator in Transdermal Formulations

Introduction

Kirti H Valia is a notable inventor based in Plainsboro, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of transdermal formulations. With a total of 4 patents to his name, Valia's work focuses on innovative methods for treating various medical conditions.

Latest Patents

Valia's latest patents include a transdermal formulation of xanomeline, which provides a method for treating Alzheimer's Disease. This invention offers desired transdermal xanomeline patch formulations that can improve patient outcomes. Another significant patent involves a transdermal formulation for treating conditions associated with muscarinic receptor modulation, utilizing a specific compound known as 3-�4-(butylthio)-1,2,5-thiadiazol-3-yl!-1-azabicyclo-�2.2.2!octane. This invention also provides desired transdermal patch formulations for this compound.

Career Highlights

Kirti H Valia is currently associated with Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation in healthcare. His work at Eli Lilly has allowed him to focus on developing advanced therapeutic solutions that address critical health issues.

Collaborations

Valia has collaborated with notable colleagues, including Harlan E Shannon and Lisa A Shipley, who contribute to the innovative environment at Eli Lilly. Their combined expertise enhances the development of groundbreaking pharmaceutical products.

Conclusion

Kirti H Valia's contributions to transdermal formulations represent a significant advancement in the treatment of various medical conditions. His innovative patents and collaborations continue to shape the future of pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…